Financial Ratios

AURO LABORATORIES LTD.

NSE : NABSE : 530233ISIN CODE : INE292C01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE187.554.8 (+2.63 %)
PREV CLOSE ( ) 182.75
OPEN PRICE ( ) 189.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8981
TODAY'S LOW / HIGH ( )181.05 192.50
52 WK LOW / HIGH ( ) 63197.4
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)3.924.5611.526.517.06
   CEPS(Rs)5.646.2013.188.158.68
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)54.8750.5845.8634.4927.94
   Tax Rate(%)29.1326.5731.6628.1327.51
Margin Ratios
   Core EBITDA Margin(%)8.309.0920.7214.3214.94
   EBIT Margin(%)8.059.2420.2114.2014.83
   Pre Tax Margin(%)6.517.6219.3612.8812.96
   PAT Margin (%)4.625.5913.239.269.40
   Cash Profit Margin (%)6.657.5915.1411.6011.55
Performance Ratios
   ROA(%)4.405.8719.3412.3213.78
   ROE(%)7.439.4728.6720.8428.95
   ROCE(%)9.9212.2038.8824.8029.12
   Asset Turnover(x)0.951.051.461.331.47
   Sales/Fixed Asset(x)2.082.052.251.852.13
   Working Capital/Sales(x)3.072.952.903.715.37
Efficiency Ratios
   Fixed Capital/Sales(x)0.480.490.440.540.47
   Receivable days89.7775.0344.0059.5365.79
   Inventory Days55.2424.4022.2330.9918.96
   Payable days83.5659.0867.0573.9766.85
Valuation Parameters
   PER(x)13.9521.987.044.838.42
   PCE(x)9.6816.196.153.866.85
   Price/Book(x)1.001.981.770.912.13
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.721.260.720.390.88
   EV/Core EBITDA(x)7.1311.183.262.365.16
   EV/EBIT(x)8.9313.593.572.745.91
   EV/CE(x)0.681.160.930.531.23
   M Cap / Sales0.641.230.930.450.79
Growth Ratio
   Net Sales Growth(%)3.99-6.2423.89-6.4814.78
   Core EBITDA Growth(%)-6.71-52.3565.67-8.9115.71
   EBIT Growth(%)-9.37-57.1376.27-10.4116.86
   PAT Growth(%)-14.15-60.3877.08-7.8424.65
   EPS Growth(%)-14.15-60.3877.08-7.8424.65
Financial Stability Ratios
   Total Debt/Equity(x)0.190.440.110.150.46
   Current Ratio(x)1.951.863.032.931.87
   Quick Ratio(x)1.301.642.752.261.53
   Interest Cover(x)5.235.6923.9210.767.95
   Total Debt/Mcap(x)0.190.220.060.160.22

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.